Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Mónica Vázquez-Díaz"'
Autor:
Borja Hernández-Breijo, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, Carlota García-Hoz, Israel Nieto-Gañán, Cristina Sobrino, Javier Bachiller-Corral, Mariana Díaz-Almirón, Ana Martínez-Feito, Teresa Jurado, Paloma Lapuente-Suanzes, Gema Bonilla, Cristina Pijoán-Moratalla, Garbiñe Roy, Mónica Vázquez-Díaz, Alejandro Balsa, Luisa M. Villar, Dora Pascual-Salcedo, Eulalia Rodríguez-Martín
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Biological therapies, such as TNF inhibitors (TNFi), are increasing remission (REM) rates in rheumatoid arthritis (RA) patients, although these are still limited. The aim of our study was to analyze changes in the profile of peripheral blood mononucl
Externí odkaz:
https://doaj.org/article/8c1ae71a6e9749d0ab8842f0e5a17687
Autor:
Eulalia Rodríguez-Martín, Israel Nieto-Gañán, Borja Hernández-Breijo, Cristina Sobrino, Carlota García-Hoz, Javier Bachiller, Ana Martínez-Feito, Victoria Navarro-Compán, Paloma Lapuente-Suanzes, Gema Bonilla, Dora Pascual-Salcedo, Garbiñe Roy, Teresa Jurado, Pilar Nozal, Mónica Vázquez-Díaz, Alejandro Balsa, Luisa M. Villar, Chamaida Plasencia-Rodríguez
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Background: TNF inhibitors (TNFis) are widely used for the treatment of rheumatoid arthritis (RA), although the response rates to this therapy in patients with RA remains heterogeneous and < 50% achieve remission (REM).Objective: To analyze baseline
Externí odkaz:
https://doaj.org/article/699858df7a47431b9c7031068b0d7145
Autor:
Patricia Morán-Álvarez, África Andreu-Suárez, Liz Caballero-Mota, Susanna Gassiot-Riu, Rubén Berrueco-Moreno, Joan Calzada-Hernández, Jordi Antón-López, Mónica Vázquez-Díaz, Alina Boteanu
Publikováno v:
Rheumatology. 61:4465-4471
Objective To identify the variables associated with the development of non-criteria manifestations in the presence of antiphospholipid antibodies (aPLs) in a paediatric cohort. Methods Multicentric historical cohort study of children under the age of
Autor:
Alejandro José Ravelo Marrero, Carlos Antonio Guillén Astete, Miriam Menacho Román, Marta Rosillo Coronado, José Manuel Del Rey Sánchez, Ana Gómez Lozano, María Andreína Terán Tinedo, Mónica Vázquez Díaz, Ignacio Arribas Gómez
Publikováno v:
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio. 3:51-58
Objectives We evaluated the prevalence of 25-hydroxyvitamin D (25-(OH)D) deficiency in our setting according to season, sex, and age. We also studied the association with parathyroid hormone (PTH) levels. Methods The study population comprised all pa
Publikováno v:
JCR: Journal of Clinical Rheumatology. 27:e575-e579
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 28(8)
Autor:
Mónica, Vázquez-Díaz
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(2)
Autor:
María Ángeles Blázquez-Cañamero, Mónica Vázquez-Díaz, J. Bachiller-Corral, Ana Rodriguez-Garcia, Carlos de la Puente, Alina Boteanu, Cristina Sobrino, Marta Valero, Carmen Medina-Quiñones, Carlos Guillén-Astete, Maria Jesus Garcia-Villanueva, M. Consuelo Diaz-Miguel, Jose Luis Morell-Hita, Marcelino Revenga, Carmen Larena, Sandra Garrote
Publikováno v:
The Journal of Rheumatology. 48:1098-1102
Objective.To describe the cohort of patients with inflammatory rheumatic diseases (IRD) hospitalized due to SARS-CoV-2 infection in the Ramón y Cajal Hospital, and to determine the increased risk of severe coronavirus disease 2019 (COVID-19) in pati
Autor:
Marta, Valero, Francisco Javier, Bachiller-Corral, Anthony Blanco, Boris, Maria Angeles, Blázquez, Maria Consuelo, Díaz-Miguel, María Jesús, García-Villanueva, María Carmen, Larena, Jose Luis, Morell, Carlos, De la Puente, Ana, Rodríguez-García, Mónica, Vázquez-Díaz, Anna, Moltó
Publikováno v:
Joint Bone Spine. 90:105505
To evaluate the properties of a single question to determine patient perception of remission and disease activity; to compare this with existing definitions for remission and low disease activity (LDA).Single-center, cross-sectional study in a tertia
Autor:
Alina Boteanu, Fernando López-Gutiérrez, Iván Del Bosque-Granero, Laura Calvo-Sanz, Verónica García-García, Mónica Vázquez-Díaz, J. Bachiller-Corral, M Andreína Terán-Tinedo, Jesús Loarce-Martos, Antía García-Fernández
Publikováno v:
Rheumatology International
The objective of this study is to describe the characteristics and outcomes of rheumatic and musculoskeletal disease (RMD) patients who were treated with rituximab and had suspected or confirmed severe acute respiratory syndrome coronavirus 2 (SARS-C